消瘰散治疗颈部淋巴结核的临床观察
2017-09-09刘启如魏嵋方平安袁术生李佳萌
刘启如+魏嵋+方平安+袁术生+李佳萌
[摘要] 目的 探讨消瘰散治疗颈部淋巴结结核的临床疗效。 方法 将157例患者随机分为两组,治疗组80例,在采用常规抗结核药治疗的同时,在对照组基础上口服消瘰散治疗。对照组77例,采用较大的病灶清除或脓肿切开引流,同时予以全身化疗。 结果 对照组总有效率为80.52%,治疗组总有效率为98.75%,两组比较,差异有统计学意义(P<0.05) 。随访1年以上,对照组中8例复发,治疗组2例复发,两组比较,差异有统计学意义(P<0.05)。结论 消瘰散治疗颈部淋巴结结核疗效显著,促进病灶吸收,且复发率低。
[关键词] 颈部;淋巴结;结核;中药;消瘰散;抗结核药物
[中图分类号] R522 [文献标识码] B [文章编号] 1673-9701(2017)22-0107-03
[Abstract] Objective To investigate the curative effect of Xiaoluo powder in the treatment of neck lymph node tuberculosis. Methods 157 patients were randomly divided into two groups. The treatment group(n=80) was treated with oral Xiaoluo powder based on the treatment in the control group, while using conventional anti-tuberculosis drugs at the same time. The control group(n=77) was given larger lesion removal or abscess incision and drainage, combined with systemic chemotherapy. Results The total effective rate was 80.52% in the control group and 98.75% in the treatment group, and the difference between the two groups was statistically significant(P<0.05). The patients were followed up for more than one year. There were 8 cases of recurrence in the control group and 2 cases of recurrence in the treatment group. the two groups, and the difference between the two groups was statistically significant(P<0.05). Conclusion Xiaoluo powder has significant curative effect in the treatment of neck lymph node tuberculosis, which promotes the absorption of lesions, and the recurrence rate is low.
[Key words] Neck; Lymph node; Tuberculosis; Traditional Chinese medicine; Xiaoluo powder; Anti-tuberculosis drugs
結核病是由结核分枝杆菌引起的慢性传染病,包括肺结核和肺外结核。淋巴结核是肺外结核中最常见的,占肺外结核的30%~40%。尤其是免疫力低下的青少年及儿童发病率逐渐增多[1],且以女性多见[2]。全身淋巴结均可发生结核病,但以颈部、腋下、腹股沟最常见,以颈部淋巴结结核最为常见[3],其中90%为颈部淋巴结核[4],可能与口腔及咽部黏膜下淋巴网特别丰富有关。目前治疗颈部淋巴结结核的主要方法是使用抗结核药物进行化疗。但是,抗结核药物不容易渗透入淋巴组织,因肿大的淋巴结外有纤维包膜,起到屏障隔离作用,使常规抗结核药物较难渗透入病灶内,常导致病变反复发作,病程持久,从而导致治疗效果不理想[5],另外,淋巴结结核的病灶容易出现破溃、坏死、脓肿,有的患者出现瘘管、窦道,使治疗时间延长,延长了服药时间,增加了药物的不良反应的发生率,降低了患者的服药依从性。
1 资料与方法
1.1 一般资料
选取本院2006年3月~2015年3月感染科收治的住院患者157例,随机分为治疗组和对照组,治疗组80例,对照组77例。……
